These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5932052)

  • 1. [Are vasodilators indicated in the treatment of obliterative arteriopathy of the lower limbs?].
    Cuypers Y; Baudinet V; Collignon P; Joris H; Kulbertus H; Rutten F
    Rev Med Liege; 1966 Apr; 21(8):185-8. PubMed ID: 5932052
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phonoangiographic demonstration of the effect of various vasodilators on patients with peripheral obliterans arteriosclerosis].
    Meciani L; Tealdi D; Santa A; Ricci G
    Minerva Cardioangiol; 1969 Nov; 17(11):942-7. PubMed ID: 5404822
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of vasodilators in peripheral arterial insufficiency].
    Hansteen V; Lorentsen E
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1731-4. PubMed ID: 5111131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Bednarczyk-Kałuzna M
    Przegl Lek; 1982; 39(9):617-20. PubMed ID: 7178532
    [No Abstract]   [Full Text] [Related]  

  • 5. [Continuous intra-arterial infusions in obliterating diseases of the lower limbs].
    Chudakov MI; Vorotyntsev SF
    Khirurgiia (Mosk); 1974 May; (5):87-90. PubMed ID: 4457694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of vazaprostan in the treatment of multifocal peripheral obliterating lesions of arteries of the lower limbs].
    Driuk NF; Mishalov VG; Pavlichenko LN
    Klin Khir (1962); 1994; (10):26-8. PubMed ID: 7602901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current news in the pharmacological and surgical treatment of chronic, peripheral, obliterating arterial diseases of the lower limbs].
    Argenteri A; Bagliani A; Borri P; Ugolini U
    Clin Ter; 1974 Aug; 70(3):281-91. PubMed ID: 4423739
    [No Abstract]   [Full Text] [Related]  

  • 8. [Medical treatment of acute arterial obliteration in the limbs].
    Serradimigni A; Bory M; Poggi L; Audier M
    Rev Atheroscler (Paris); 1968; 10(2):3-8. PubMed ID: 5759950
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of surheme on improved blood flow in limbs].
    Wesolowski J; Hubl S; Godziemba-Maliszewska E
    Wiad Lek; 1972 Jul; 25(14):1297-300. PubMed ID: 5054661
    [No Abstract]   [Full Text] [Related]  

  • 10. [Surheme in chronic obliterative arteriopathies of the lower limbs].
    Desruelles J; Waucampt JJ
    Lille Med; 1971 Jan; 16():Suppl 1:224-9. PubMed ID: 5162043
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of vasoprostan in the treatment of obliterating atherosclerosis of the lower limbs].
    Sukharev II; Guch AA
    Klin Khir (1962); 1994; (7):22-4. PubMed ID: 7823491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
    Kurbangaleev SM; Savel'ev IuS
    Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rheodextran, vasodilating infusion and blood flow properties in patients with obliterative atherosclerosis of the lower extremities].
    Bulvas M; Linhart J
    Vnitr Lek; 1982 Sep; 28(9):902-7. PubMed ID: 6183828
    [No Abstract]   [Full Text] [Related]  

  • 14. [Muscular blood flow in occlusive diseases of arteries of the lower limbs and the effect of medicinal preparations].
    Lyskova MN; Kuz'min VP; Tsypliaev VA; Bogoliubov VM
    Klin Med (Mosk); 1975 Apr; 53(4):47-50. PubMed ID: 1152370
    [No Abstract]   [Full Text] [Related]  

  • 15. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
    Toth L
    Med Pregl; 1975; 28(3-4):181-3. PubMed ID: 1177851
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of regional artificial circulation in the treatment of obliterating thrombosis of the lower limbs].
    Dutkevich IG; Farshatov MN; Glebov IuI; Dekster BG
    Vestn Khir Im I I Grek; 1966 Jun; 96(6):122-6. PubMed ID: 6000568
    [No Abstract]   [Full Text] [Related]  

  • 17. [Conservative treatment of arteriosclerosis obliterans of the lower limbs].
    Kancelarczyk WL; Rymaszewski Z
    Kardiol Pol; 1981; 24(8):571-7. PubMed ID: 6169868
    [No Abstract]   [Full Text] [Related]  

  • 18. [New information on obliterative disease of the peripheral vessels and its treatment].
    Masek O
    Vnitr Lek; 1968 Mar; 14(3):301-3. PubMed ID: 5638968
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effectiveness of therapeutic measures in arterial occlusion disease].
    Koch A; Klett M; Hild R
    Dtsch Med J; 1970 May; 21(9):606-22. PubMed ID: 5481584
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our current concept of the treatment of atheromatous obliterative arteriopathy of the lower limbs].
    Cuypers Y; Baudinet V; Collignon P; Joris H; Kulbertus H; Rutten F
    Rev Med Liege; 1966 Apr; 21(8):188-90. PubMed ID: 5932053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.